Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18822227rdf:typepubmed:Citationlld:pubmed
pubmed-article:18822227lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:18822227lifeskim:mentionsumls-concept:C0011860lld:lifeskim
pubmed-article:18822227lifeskim:mentionsumls-concept:C0021641lld:lifeskim
pubmed-article:18822227lifeskim:mentionsumls-concept:C1523987lld:lifeskim
pubmed-article:18822227pubmed:issue39lld:pubmed
pubmed-article:18822227pubmed:dateCreated2008-9-29lld:pubmed
pubmed-article:18822227pubmed:abstractTextThe benefits and drawbacks of exenatide as an alternative to insulin in the treatment of poorly regulated type 2 diabetes are reviewed. Exenatide and insulin have equal effects on HbA1c but exenatide causes weight-loss and improved postprandial glucose control. Nausea is reported by nearly half of patients treated with exenatide. Exenatide can be considered in the overweight patient without extremely elevated HbA1c but nausea could pose a substantial hurdle for successful treatment.lld:pubmed
pubmed-article:18822227pubmed:languagedanlld:pubmed
pubmed-article:18822227pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18822227pubmed:citationSubsetIMlld:pubmed
pubmed-article:18822227pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18822227pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18822227pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18822227pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18822227pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18822227pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18822227pubmed:statusMEDLINElld:pubmed
pubmed-article:18822227pubmed:monthSeplld:pubmed
pubmed-article:18822227pubmed:issn1603-6824lld:pubmed
pubmed-article:18822227pubmed:authorpubmed-author:SandbaekAnnel...lld:pubmed
pubmed-article:18822227pubmed:authorpubmed-author:KjeldsenRasmu...lld:pubmed
pubmed-article:18822227pubmed:issnTypeElectroniclld:pubmed
pubmed-article:18822227pubmed:day22lld:pubmed
pubmed-article:18822227pubmed:volume170lld:pubmed
pubmed-article:18822227pubmed:ownerNLMlld:pubmed
pubmed-article:18822227pubmed:authorsCompleteYlld:pubmed
pubmed-article:18822227pubmed:pagination3039-43lld:pubmed
pubmed-article:18822227pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:18822227pubmed:meshHeadingpubmed-meshheading:18822227...lld:pubmed
pubmed-article:18822227pubmed:meshHeadingpubmed-meshheading:18822227...lld:pubmed
pubmed-article:18822227pubmed:meshHeadingpubmed-meshheading:18822227...lld:pubmed
pubmed-article:18822227pubmed:meshHeadingpubmed-meshheading:18822227...lld:pubmed
pubmed-article:18822227pubmed:meshHeadingpubmed-meshheading:18822227...lld:pubmed
pubmed-article:18822227pubmed:meshHeadingpubmed-meshheading:18822227...lld:pubmed
pubmed-article:18822227pubmed:meshHeadingpubmed-meshheading:18822227...lld:pubmed
pubmed-article:18822227pubmed:meshHeadingpubmed-meshheading:18822227...lld:pubmed
pubmed-article:18822227pubmed:meshHeadingpubmed-meshheading:18822227...lld:pubmed
pubmed-article:18822227pubmed:meshHeadingpubmed-meshheading:18822227...lld:pubmed
pubmed-article:18822227pubmed:meshHeadingpubmed-meshheading:18822227...lld:pubmed
pubmed-article:18822227pubmed:meshHeadingpubmed-meshheading:18822227...lld:pubmed
pubmed-article:18822227pubmed:year2008lld:pubmed
pubmed-article:18822227pubmed:articleTitle[Exenatide--an alternative to insulin in the treatment of type 2 diabetes?].lld:pubmed
pubmed-article:18822227pubmed:affiliationHorsensgade 11, 4. sal, 8000 Arhus C. rkj@studmed.au.dklld:pubmed
pubmed-article:18822227pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18822227pubmed:publicationTypeEnglish Abstractlld:pubmed
pubmed-article:18822227pubmed:publicationTypeReviewlld:pubmed